Start Date
December 31, 2026
Primary Completion Date
April 30, 2027
Study Completion Date
September 30, 2027
Nabiximols
Nabiximols is is a yellow-brown oromucosal spray solution containing 27 mg/mL of THC and 25 mg/mL of CBD.
Placebo
The placebo is a matching oromucosal spray that is identical to the investigational study product in terms of packaging, labelling, schedule of administration, dosing instructions, and appearance.
Massachusetts General Hospital, Boston
Collaborators (1)
Jazz Pharmaceuticals
INDUSTRY
Michael, Levy M.D.,Ph.D.
OTHER